MT# [002]

Related by string. MT# [003] . MT# [001] * * MediaTek MT# . Microtune MT# . PM MT# . MT# 1ST DOWN . adecatumumab MT# . MT# tuner . MT# MEDI . BiTE antibody MT# . candidate blinatumomab MT# . AM MT# . MicroTuner MT# . Mosler MT# . antibody MT# . MT# COV . stage antibody MT# . Rolls Royce MT# . Motorola MT# . MicroTuner TM MT# *

Related by context. Frequent words. (Click for all words.) 55 XL# [003] 50 humanized monoclonal antibody 49 investigational drug 49 INCB# [002] 48 oncology indications 48 AEZS 47 MB# [004] 47 Phase 2b clinical 47 RDEA# 47 Phase 1b 46 PLX# 46 FOLOTYN 46 perifosine 46 Phase IIa clinical 46 Phase Ib 46 MDV# 46 RG# [001] 45 antitumor activity 45 carfilzomib 44 investigational compound 44 AZD# 44 randomized Phase 44 dose escalation study 44 pharmacodynamic 44 T DM1 44 Phase 2a clinical 44 Phase IIb clinical 43 Phase 2a 43 CB# [002] 43 Vectibix 43 ARQ 43 ENMD 43 hematologic malignancies 43 preclinical 43 NKTR 43 elesclomol 43 Genasense 43 MGCD# [002] 42 satraplatin 42 solid tumors 42 picoplatin 42 Phase III 42 ITMN 42 preclinical studies 42 metastatic colorectal cancer 42 hematological malignancies 42 taxane 42 pivotal Phase III 41 Locteron 41 APD# 41 monotherapy 41 Phase 2b 41 advanced NSCLC 41 Phase 2b study 41 ispinesib 41 CYT# 41 hepatocellular carcinoma 41 tivozanib 41 laquinimod 41 Phase III clinical 40 Phase IIa 40 Albuferon 40 preclinical models 40 Phase II 40 HCV 40 pharmacokinetic profile 40 Hematide 40 REVLIMID 40 CK # 40 Phase IIb 40 PRX # 39 NSCLC 39 antiviral activity 39 ARRY 39 alemtuzumab 39 Prochymal 39 sorafenib 39 Nexavar 39 bavituximab 39 bortezomib 39 metastatic melanoma 39 SPP# [001] 38 docetaxel 38 ERBITUX 38 TMC# [001] 38 Phase IIb trial 38 mipomersen 38 sunitinib 37 dose escalation 37 CUDC 37 ALKS 37 erlotinib 37 tolerability profile 36 pivotal Phase 36 Ceplene 36 PROVENGE 36 ANA# 36 rituximab 35 gefitinib 34 gemcitabine 33 ipilimumab

Back to home page